Chemical Composition of <i>Anabasis articulata</i>, and Biological Activity of Greenly Synthesized Zinc Oxide Composite Nanoparticles (Zn-NPs): Antioxidant, Anticancer, and Larvicidal Activities

The synthesis of nanoparticles utilizing green techniques is becoming increasingly important due to its low cost, biocompatibility, high productivity, and eco-friendliness. Herein, the current work focused on the biosynthesis, characterization, and biological applications of zinc oxide nanoparticles (ZnO-NPs) from <i>Anabasis articulata</i>, including antioxidant anticancer and larvicidal properties, as well as modifications to the phytochemical ingredients. Hence, the tannin, phenolic, and flavonoid concentrations of the produced nanoparticle samples were lower than those of the original aqueous extract. When compared to the results of ascorbic acid (12.78 mg/mL), the produced extract of <i>A. articulata</i> and its zinc nanoparticles showed remarkable efficacy as antioxidant agents with IC₅₀ values of 27.48 and 69.53 mg/mL, respectively. A normal lung fibroblast cell line (WI-38) and three tumor cells were used to test the compounds’ anticancer properties. With an IC₅₀ of 21.19 µg/mL, the ZnO-NPs of <i>A. articulata</i> showed the greatest cytotoxicity against HePG-2 cell lines. Additionally, <i>A. articulata</i> zinc nanoparticles showed significant cytotoxicity against MCF-7 and PC3 tumor cell lines, with IC₅₀ values of 30.91 and 49.32 µg/mL. The biogenic ZnO-NPs had LC₅₀ and LC₉₀ values of 13.64 and 26.23 mg/L, respectively, and are very effective against <i>Aedes aegypti</i> larval instar (III). Additionally, the percentages of larval mortality increased from 28.61% at 5 ppm to 84.69% at 25 ppm after 24 h post-treatment. The overall results of this study point to the potential of <i>A. articulata</i> as a substitute biological agent for potential therapeutic/leutic uses in the medical domains and for preventing the proliferation of malarial vector insects.